Arkolith/Insider Trading/TXG/Form 4

Hindson Benjamin J.

See Remarks, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Feb 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$51K
Net Open-Market Flow
-$51K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Sell(S)5K$11.07$51K335K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML